4Bothamley GH, Rudd R, Festenstein F, Ivanyi J. Clinical value of the measurement of Mycobacterium tuberculosis speciglic antibody in pulmonary tuberculosis [J]. Thorax 1992.47(4) :270--275.
6Hu YM, Butcher PD, Sole K, Mitchison DA, Coates ARM. Protein synthesis is shutdown in dormant mycobacterium tuberculosis and is reversed by oxygen or heat shock [J]. FEMS Microbiol Lett, 1998,158(1) :139--145.
7Britton WJ,Palengira V. Improving vaccines against tuberculosis [J]. Immunal Cell Biol,2003,81(1) :34--45.
8Jackett PS, Bothamley GH, Batra HV, Mistry A,Young DB, Ivanyi J. Specificity of antibodies in pulmonary tuberculosis[J]. J Clin Mcrobiol, 1998,26(11) : 2313-- 2318.
9Zengyi Chang, Primm TP, Jakana J, Lee IH, Seryshevai I, Hi ram F,Chiu W,Gilbert HF, Quiocho FA. Mycobacterium tuberculosis 16-kDa antigen (Hsp16.3) function as an oligomeric structure in vitro to suppress thermal aggregation [J]. J Biol Chem, 1996,271(12) :7218--7223.
10Wilkinson RJ, Haslov K, Rappuoli R, Giovannoni F, Narayanan PR, Desai CR, Vordermeier HM, Pauten J, Pasvol G, Ivnyi J,Singh M. Evaluation of the recombinant 38-kilodalton antigen of mycobacterium tuberculosis of a potential immunodignostic reagent [J]. J Clin Microbiol, 1997,35(3) :553--557.
